Blood pressure apps barely work without tailored advice

Blood pressure is one of the few major health numbers people can track and influence themselves, and smartphone apps promise to make that easy: log your medication, your diet, your activity, and watch the numbers respond. But self-monitoring is a behaviour change tool, not a treatment, and it has been unclear whether app-based tracking actually translates into lower blood pressure for people already being treated for hypertension. This review set out to measure that effect and to identify which components of these apps might explain any benefit.

The researchers systematically searched 7 databases in August 2021 for randomised controlled trials of smartphone app-based self-monitoring of hypertension-related behaviours in adults, published after 2000 and in English. From 4638 articles identified, 227 went to full-text screening and 15 randomised controlled trials were included, contributing 7415 patients with hypertension to the pooled analysis. They compared app-based self-monitoring against usual care or minimal intervention, and examined effects on blood pressure, medication adherence and lifestyle behaviours, with a subgroup analysis splitting apps by whether they offered tailored advice.

App-based self-monitoring reduced systolic blood pressure by an average of 1.64 mmHg, a small but statistically significant effect, and improved medication adherence. There was a small benefit for dietary habits around high sodium food, and non-significant trends towards better physical activity, less alcohol and smoking cessation. The subgroup analysis was the striking part: apps combining self-monitoring with tailored advice cut systolic pressure by 2.92 mmHg, whereas those without managed only 0.72 mmHg, a statistically significant difference that also appeared for diastolic pressure.

This fits a broader pattern in digital health: tracking alone produces marginal changes, while tracking plus personalised feedback produces something closer to clinically meaningful ones. The subgroup comparison is suggestive rather than definitive, because it contrasts different sets of trials rather than randomising people to advice or no advice within one study. The authors call for more rigorous trials to pin down which behavioural components drive the effect and to inform policy and service decisions.

If you use an app to track your blood pressure or the habits behind it, this is a reason to expect modest effects from logging alone, and to notice whether your app actually tells you anything personalised in return. The evidence here suggests the feedback, not the tracking, carries most of the value. Even small average reductions can matter at a population level, but on an individual screen, 1.64 mmHg is a number you would struggle to notice.